CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
News|Articles|March 1, 2003
Evidence-based Antimicrobial Therapy: Responsible Use of Fluoroquinolones in Today?s Clinical Practice (PDF)
Treatment strategies from: Vincent T. Andriole, MD, Professor of Medicine, Yale University School of Medicine Attending Physician, Yale-New Haven Hospital, New Haven, Connecticut
Advertisement
Advertisement
Related to this article
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Closing the outpatient monitoring gap in cancer
2
A conversation with Jordan Herring, Ph.D., and Carlos E. Rodriguez-Diaz, Ph.D., MPHE, MCHES, about the relationship between HIV incidence in Hispanic communities and immigration policy
3
New lean MASH mouse model could guide more targeted liver disease treatment in humans
4
A conversation with Eric Seiber, Ph.D., about why defining first-episode psychosis matters
5